---
figid: PMC5677786__fimmu-08-01518-g011
figtitle: Scheme summarizing the protective effect of isoliquiritigenin (ISL) on lipopolysaccharide
  (LPS)-induced acute lung injury (ALI) and the underlying mechanisms
organisms:
- Armoracia rusticana
- Ginkgo biloba
- Glycyrrhiza uralensis
- Citrus aurantium
- Aralia continentalis
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Escherichia coli
organisms_ner:
- Bos taurus
- Homo sapiens
- Oryctolagus cuniculus
- Mus musculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC5677786
filename: fimmu-08-01518-g011.jpg
figlink: /pmc/articles/PMC5677786/figure/F11/
number: F11
caption: Scheme summarizing the protective effect of isoliquiritigenin (ISL) on lipopolysaccharide
  (LPS)-induced acute lung injury (ALI) and the underlying mechanisms. ISL treatment
  significantly alleviated LPS-induced ALI via the restriction of oxidative and inflammatory
  injury, which was associated with activation of AMP-activated protein kinase (AMPK)/Nrf2/antioxidant
  response element signaling and inhibition of NOD-like receptor protein 3 (NLRP3)
  and NF-κB pathways. Nevertheless, the inhibition of NLRP3 and NF-κB pathways by
  ISL could be Nrf2-dependent or Nrf2-independent, respectively.
papertitle: Isoliquiritigenin Activates Nuclear Factor Erythroid-2 Related Factor
  2 to Suppress the NOD-Like Receptor Protein 3 Inflammasome and Inhibits the NF-κB
  Pathway in Macrophages and in Acute Lung Injury.
reftext: Qinmei Liu, et al. Front Immunol. 2017;8:1518.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9058856
figid_alias: PMC5677786__F11
figtype: Figure
redirect_from: /figures/PMC5677786__F11
ndex: 753f3701-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5677786__fimmu-08-01518-g011.html
  '@type': Dataset
  description: Scheme summarizing the protective effect of isoliquiritigenin (ISL)
    on lipopolysaccharide (LPS)-induced acute lung injury (ALI) and the underlying
    mechanisms. ISL treatment significantly alleviated LPS-induced ALI via the restriction
    of oxidative and inflammatory injury, which was associated with activation of
    AMP-activated protein kinase (AMPK)/Nrf2/antioxidant response element signaling
    and inhibition of NOD-like receptor protein 3 (NLRP3) and NF-κB pathways. Nevertheless,
    the inhibition of NLRP3 and NF-κB pathways by ISL could be Nrf2-dependent or Nrf2-independent,
    respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFE2L2
  - TNF
  - NOS2
  - COX2
  - IL6
  - IL1B
  - IRF6
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GABPA
  - ISYNA1
  - PTGS2
  - NOS1
  - Tlr4
  - Nfe2l2
  - Tnf
  - Nos2
  - Ptgs2
  - Il6
  - Il1b
  - loh
  - SNF4Agamma
  - AMPKalpha
  - Keap1
  - cnc
  - egr
  - Inos
  - Nos
  - nfe2l2a
  - tnfb
  - nos1
  - il6
  - il1b
---
